Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations: Focus on oral corticosteroids

Timothy Self, Shanise J. Patterson, Arthur S. Headley, Christopher K. Finch

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is associated with a huge burden of suffering and healthcare expenditures. Patients hospitalized due to COPD have increased risk of death. Starting in 2015, reimbursements by the Centers for Medicaid Medicare Services will be significantly reduced to hospitals with excess 30 day readmissions for COPD. Oral corticosteroid (OCS) therapy is established in improving outcomes in COPD patients treated in the emergency department and hospital. The objective of this article is to review the evidence evaluating home OCS treatment of COPD exacerbations as part of a comprehensive self-management action plan.

Methods: We reviewed the English literature via PubMed, Embase, and Scopus using the search terms: chronic obstructive pulmonary disease exacerbations AND: oral corticosteroids, prednisone, prednisolone, methylprednisolone, treatment, self-management, disease management, written action plans. When pertinent articles were found, we reviewed the relevant articles cited.

Findings: Two randomized trials enrolling 933 patients provide evidence of reduced rates of hospitalization by using comprehensive COPD action plans, including OCS therapy. Three trials with 790 patients enrolled did not reveal reduced rates of hospitalization. Among all five trials together, there were no differences in deaths (76 in the intervention groups [home action plans]; 81 in the usual care groups). Additional studies not assessing hospitalizations have found home use of OCSs increases time to the next exacerbation and decreases recovery time.

Conclusion: Further randomized trials are needed to establish that home use of OCS therapy, as part of a comprehensive action plan, reduces the rate of hospitalizations. Such action plans should include structured patient education, early initiation of OCSs, oral antibiotics, and frequent telephone reinforcement and support from case management.

Original languageEnglish (US)
Pages (from-to)2607-2615
Number of pages9
JournalCurrent Medical Research and Opinion
Volume30
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Chronic Obstructive Pulmonary Disease
Disease Progression
Adrenal Cortex Hormones
Hospitalization
Self Care
Group Homes
Literature
Therapeutics
Centers for Medicare and Medicaid Services (U.S.)
Methylprednisolone
Case Management
Patient Education
Disease Management
Health Expenditures
Prednisone
Prednisolone
Psychological Stress
Telephone
PubMed
Hospital Emergency Service

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations : Focus on oral corticosteroids. / Self, Timothy; Patterson, Shanise J.; Headley, Arthur S.; Finch, Christopher K.

In: Current Medical Research and Opinion, Vol. 30, No. 12, 01.12.2014, p. 2607-2615.

Research output: Contribution to journalArticle

Self, Timothy ; Patterson, Shanise J. ; Headley, Arthur S. ; Finch, Christopher K. / Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations : Focus on oral corticosteroids. In: Current Medical Research and Opinion. 2014 ; Vol. 30, No. 12. pp. 2607-2615.
@article{bdd3e1a01fd24d79b577d10b86e48165,
title = "Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations: Focus on oral corticosteroids",
abstract = "Objective: Chronic obstructive pulmonary disease (COPD) is associated with a huge burden of suffering and healthcare expenditures. Patients hospitalized due to COPD have increased risk of death. Starting in 2015, reimbursements by the Centers for Medicaid Medicare Services will be significantly reduced to hospitals with excess 30 day readmissions for COPD. Oral corticosteroid (OCS) therapy is established in improving outcomes in COPD patients treated in the emergency department and hospital. The objective of this article is to review the evidence evaluating home OCS treatment of COPD exacerbations as part of a comprehensive self-management action plan.Methods: We reviewed the English literature via PubMed, Embase, and Scopus using the search terms: chronic obstructive pulmonary disease exacerbations AND: oral corticosteroids, prednisone, prednisolone, methylprednisolone, treatment, self-management, disease management, written action plans. When pertinent articles were found, we reviewed the relevant articles cited.Findings: Two randomized trials enrolling 933 patients provide evidence of reduced rates of hospitalization by using comprehensive COPD action plans, including OCS therapy. Three trials with 790 patients enrolled did not reveal reduced rates of hospitalization. Among all five trials together, there were no differences in deaths (76 in the intervention groups [home action plans]; 81 in the usual care groups). Additional studies not assessing hospitalizations have found home use of OCSs increases time to the next exacerbation and decreases recovery time.Conclusion: Further randomized trials are needed to establish that home use of OCS therapy, as part of a comprehensive action plan, reduces the rate of hospitalizations. Such action plans should include structured patient education, early initiation of OCSs, oral antibiotics, and frequent telephone reinforcement and support from case management.",
author = "Timothy Self and Patterson, {Shanise J.} and Headley, {Arthur S.} and Finch, {Christopher K.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1185/03007995.2014.934795",
language = "English (US)",
volume = "30",
pages = "2607--2615",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Action plans to reduce hospitalizations for chronic obstructive pulmonary disease exacerbations

T2 - Focus on oral corticosteroids

AU - Self, Timothy

AU - Patterson, Shanise J.

AU - Headley, Arthur S.

AU - Finch, Christopher K.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Objective: Chronic obstructive pulmonary disease (COPD) is associated with a huge burden of suffering and healthcare expenditures. Patients hospitalized due to COPD have increased risk of death. Starting in 2015, reimbursements by the Centers for Medicaid Medicare Services will be significantly reduced to hospitals with excess 30 day readmissions for COPD. Oral corticosteroid (OCS) therapy is established in improving outcomes in COPD patients treated in the emergency department and hospital. The objective of this article is to review the evidence evaluating home OCS treatment of COPD exacerbations as part of a comprehensive self-management action plan.Methods: We reviewed the English literature via PubMed, Embase, and Scopus using the search terms: chronic obstructive pulmonary disease exacerbations AND: oral corticosteroids, prednisone, prednisolone, methylprednisolone, treatment, self-management, disease management, written action plans. When pertinent articles were found, we reviewed the relevant articles cited.Findings: Two randomized trials enrolling 933 patients provide evidence of reduced rates of hospitalization by using comprehensive COPD action plans, including OCS therapy. Three trials with 790 patients enrolled did not reveal reduced rates of hospitalization. Among all five trials together, there were no differences in deaths (76 in the intervention groups [home action plans]; 81 in the usual care groups). Additional studies not assessing hospitalizations have found home use of OCSs increases time to the next exacerbation and decreases recovery time.Conclusion: Further randomized trials are needed to establish that home use of OCS therapy, as part of a comprehensive action plan, reduces the rate of hospitalizations. Such action plans should include structured patient education, early initiation of OCSs, oral antibiotics, and frequent telephone reinforcement and support from case management.

AB - Objective: Chronic obstructive pulmonary disease (COPD) is associated with a huge burden of suffering and healthcare expenditures. Patients hospitalized due to COPD have increased risk of death. Starting in 2015, reimbursements by the Centers for Medicaid Medicare Services will be significantly reduced to hospitals with excess 30 day readmissions for COPD. Oral corticosteroid (OCS) therapy is established in improving outcomes in COPD patients treated in the emergency department and hospital. The objective of this article is to review the evidence evaluating home OCS treatment of COPD exacerbations as part of a comprehensive self-management action plan.Methods: We reviewed the English literature via PubMed, Embase, and Scopus using the search terms: chronic obstructive pulmonary disease exacerbations AND: oral corticosteroids, prednisone, prednisolone, methylprednisolone, treatment, self-management, disease management, written action plans. When pertinent articles were found, we reviewed the relevant articles cited.Findings: Two randomized trials enrolling 933 patients provide evidence of reduced rates of hospitalization by using comprehensive COPD action plans, including OCS therapy. Three trials with 790 patients enrolled did not reveal reduced rates of hospitalization. Among all five trials together, there were no differences in deaths (76 in the intervention groups [home action plans]; 81 in the usual care groups). Additional studies not assessing hospitalizations have found home use of OCSs increases time to the next exacerbation and decreases recovery time.Conclusion: Further randomized trials are needed to establish that home use of OCS therapy, as part of a comprehensive action plan, reduces the rate of hospitalizations. Such action plans should include structured patient education, early initiation of OCSs, oral antibiotics, and frequent telephone reinforcement and support from case management.

UR - http://www.scopus.com/inward/record.url?scp=84914163583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914163583&partnerID=8YFLogxK

U2 - 10.1185/03007995.2014.934795

DO - 10.1185/03007995.2014.934795

M3 - Article

C2 - 24926733

AN - SCOPUS:84914163583

VL - 30

SP - 2607

EP - 2615

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 12

ER -